Tel Aviv, May 5 : Israeli Defence Minister Naftali Bennett has claimed that Israel Institute for Biological Research (IIBR) has made a “significant breakthrough” in developing a Coronavirus antibody.
Bennett, on Monday, expressed his joy at this 'breakthrough' calling it an ‘amazing achievement’ and declared that the defence research facility researchers have completed the development phase and are working to patent the drug. He said that the facility is approaching pharma companies so that mass production of the drug can start. The Times of Israel quoted Bennett's official statement describing the antibody “Antibody that attacks the virus in a monoclonal way and can neutralize it within the bodies of those ill,” the Minister released this statement after his visit to the IIBR, a secretive unit that works under the Israeli Prime Minister’s Office.
The statement, however, did not clarify whether human trials have been conducted or not. Around the world about 100 research groups are engaged in developing a vaccine against the Coronavirus, with nearly a dozen in the early stages of human trials or poised to start human trials. (UNI)